Health
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, September 17, 2020. Mike Blake | Reuters An Eli Lilly experimental drug helped patients lose about 26% of their weight on average following extended use or intensive lifestyle changes, according to results from two studies released Thursday. It’s the […]
Read More
New bill aims to help low-income Americans with disabilities build emergency savings through a federal match
Halfpoint Images | Moment | Getty Images The Americans with Disabilities Act was signed into law 33 years ago to protect people with disabilities from discrimination. But disabled people still face major hurdles when it comes to building wealth. To help make it easier for disabled individuals with lower incomes to save, Sen. Bob Casey, […]
Read More
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. Stefan Trumpf | Picture Alliance | Getty Images U.K. health authorities on Wednesday said they are reviewing obesity and diabetes drugs like Novo Nordisk‘s Wegovy and Ozempic after some patients who took the treatments […]
Read More
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
Budrul Chukrut | Lightrocket | Getty Images GlaxoSmithKline CEO Emma Walmsley on Wednesday said she expects uptake for the company’s new RSV vaccine to start off slower than it did for its blockbuster shingles shot. But she is confident that the new vaccine will drive future sales. “I think the uptake on this we need […]
Read More
Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait
Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. Stefan Trumpf | Picture Alliance | Getty Images Danish pharmaceutical giant Novo Nordisk is set to launch its hugely popular Wegovy obesity drug in Germany this month, but it could be some time before […]
Read More
Why Cramer thinks this retailer is the ‘ultimate trade-down play’
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Health care in focus ‘Ultimate trade-down play’ Watch the Bullpen 1. Health care in focus Club holdings Danaher (DHR) and GE Healthcare (GEHC) reported better-than-expected earnings before the bell Tuesday. […]
Read More
Morgan Stanley sees profound shift in diabetes treatment boosting opportunity for weight-loss drugs
Morgan Stanley analysts said they are seeing a profound shift in the way diabetes is being treated, with doctors intensifying the focus on weight management, which is accelerating the uptake of GLP-1 medications. What’s more, the analysts anticipate that over the next 24 months, this weight-centric approach will start to spread to other health complications […]
Read More
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday said it expects to cut approximately 1,000 jobs, or about 11% of its workforce, to save costs as the biotech company prepares to launch its newly approved Alzheimer’s drug Leqembi. It’s the latest round of layoffs after Biogen slashed nearly 900 jobs […]
Read More
Biden administration aims to crack down on inadequate insurance for mental health care
A young woman sits on a couch with her therapist. Sdi Productions | E+ | Getty Images The Biden administration plans to crack down on health insurance plans that discriminate against people who need mental health care and substance abuse treatments. A proposed rule published Tuesday by the Health and Human Services, Labor and Treasury […]
Read More
Morgan Stanley names this health insurance stock a top pick, sees more than 20% upside
Morgan Stanley thinks it’s time to buy shares of Elevance Health . The bank listed the stock as a top pick in a Tuesday note and reiterated an overweight rating on it. Morgan Stanley’s $585 price target implies roughly 24% upside from Monday’s $471.16 close. Morgan Stanley analyst Michael Ha said the health insurance company […]
Read More